Blueprint Medicines
Biotechnology & Life Sciences
Where
45 Sidney Street, Cambridge, MA, 02139
Overview
Blueprint Medicines is a precision therapy company that invents life-changing medicines for genomically defined cancers and rare immunological diseases. The enterprise discovered and commercializes Ayvakit, a selective kinase inhibitor that treats systemic mastocytosis and gastrointestinal stromal tumors harboring specific genetic mutations. By combining deep structural biology expertise with kinase design, Blueprint Medicines delivers therapies that target the molecular roots of human disease.